301 Treatment of systemic lupus erythematosus patients with upadacitinib results in the coordinated inhibition of type 1 IFN-related biomarkers: biomarker analysis of the M19–130 (SLEek) phase 2 study
oleh: Joan T Merrill, Alan Friedman, Thierry Sornasse, Marie-Claude Gaudreau, James Fann, Shalina Contrepois
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2024-05-01 |
Deskripsi
No description available for this item.